Harmony Biosciences Holdings Inc Ordinary Shares HRMY
News
HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
HARMONY BIOSCIENCES TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 6, 2024
Harmony Biosciences Gets FDA Orphan Designation for Pitolisant in Prader-Willi Syndrome
Harmony Biosciences Stock Up as FDA Rejects to Reevaluate Narcolepsy Treatment Patent